[Are drug-coated stents too expensive?].
Kaulen
Hildegard
H
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000191:economics; D002455:Cell Division / Q000187:drug effects; D023921:Coronary Stenosis / Q000628:therapy*; D003692:Delayed-Action Preparations; D005858:Germany; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000191:economics; D017239:Paclitaxel / Q000008:administration & dosage / Q000191:economics; D055502:Secondary Prevention; D020123:Sirolimus / Q000008:administration & dosage / Q000191:economics; D015607:Stents / Q000145:classification / Q000191:economics*
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus